Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as 1: Liothyronine Sodium Tablets
1: Liothyronine · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Liothyronine Sodium Tablets, 50 mcg |
| 2 | ACTIVE_COMPARATOR | Cytomel® Tablets, 50 mcg |
| Name | Type | Description |
|---|---|---|
| 1: Liothyronine Sodium Tablets | DRUG | Liothyronine Sodium Tablets, 50 mcg 2 x 50 mcg, single-dose, fasting |
| 2: Cytomel® Tablets | DRUG | Cytomel® Tablets, 50 mcg 2 x 50 mcg, single-dose, fasting |
Inclusion Criteria: * healthy males and/or non-pregnant, non-lactating females, 18 years and older * able to swallow medication Exclusion Criteria: * institutionalized subjects * history of any significant disease * use of any prescription or OTC medications within 14 days prior to start of study...
Liothyronine is a small molecule drug developed by Viatris Inc. (ticker VTRS) and is also known as Liothyronine Sodium Tablets. It has been studied in healthy adult volunteers in the United States. The program includes one completed Phase 1 trial with 31 participants.
Liothyronine has been evaluated in healthy volunteers rather than in a patient population. The single completed Phase 1 study enrolled healthy adults aged 18 years and older of all sexes in the United States. No disease indication is listed for this program.
Liothyronine is developed by Viatris Inc., which trades under the ticker VTRS. The product referenced in the clinical program is Liothyronine Sodium Tablets. Viatris sponsored the Phase 1 study of the drug conducted in the United States.
Liothyronine is in Phase 1 development. The program has one completed Phase 1 trial and no active trials. It is an investigational program in clinical development, and the available information does not indicate that it is approved by the FDA.
Liothyronine has been studied in one completed Phase 1 trial, NCT00978055, titled Fasting Study of Liothyronine Sodium Tablets (50 Mcg) to Cytomel Tablets (50 Mcg). The trial enrolled 31 healthy adult volunteers in the United States, was randomized, and used an active control.
Yes, Liothyronine Sodium Tablets is another name for liothyronine. The Phase 1 study NCT00978055 compared Liothyronine Sodium Tablets at 50 mcg with Cytomel tablets at 50 mcg in healthy volunteers. Both names refer to the same drug developed by Viatris Inc.